Castle Biosciences, Inc.CSTLNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P6
Near historical low
vs 2Y Ago
-5.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -365.47% |
| Q3 2025 | -111.08% |
| Q2 2025 | 117.50% |
| Q1 2025 | -369.53% |
| Q4 2024 | 322.65% |
| Q3 2024 | -74.56% |
| Q2 2024 | 452.01% |
| Q1 2024 | 1.78% |
| Q4 2023 | 62.64% |
| Q3 2023 | 63.23% |
| Q2 2023 | 35.70% |
| Q1 2023 | -41.64% |
| Q4 2022 | -1.82% |
| Q3 2022 | -1128.70% |
| Q2 2022 | 93.31% |
| Q1 2022 | -282.94% |
| Q4 2021 | 45.47% |
| Q3 2021 | -34.13% |
| Q2 2021 | -105.40% |
| Q1 2021 | 12.46% |
| Q4 2020 | -6.54% |
| Q3 2020 | -233.50% |
| Q2 2020 | -341.40% |
| Q1 2020 | -72.26% |
| Q4 2019 | -64.87% |
| Q3 2019 | 560.91% |
| Q2 2019 | 6.55% |
| Q1 2019 | -135.10% |
| Q4 2018 | 212.13% |
| Q3 2018 | -9.35% |
| Q2 2018 | 13.10% |
| Q1 2018 | 0.00% |